Drug Approval | February 18, 2023
Themis gets DCGI approval of Remifentanil Hydrochloride 1mg/2mg injection for import and marketing
Themis will market this drug with the brand name REMITHEM.
Themis will market this drug with the brand name REMITHEM.
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
Zidavi is recommended by the Infectious Disease Society of America
Medical Tourism will boost India’s economy
The company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations
Dr. Mandaviya and Dharmendra Pradhan dedicate Burns Centre at AIIMS; Lays foundation stone of Critical Care Hospital Building, and award 40 gold medals to meritorious students
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Philips AI-powered interventional and diagnostic smart systems enhances diagnostic confidence, drive greater efficiency, and improve patient outcomes
Subscribe To Our Newsletter & Stay Updated
